EPCAM and neoplasm: One of the BIKE (bispecific NKcells’engager) antibodies recognizing CD16 on NK cells and EPCAM on tumor cells that facilitates ADCC but not the proliferation of NK cells was engineered by Joerg.U and colleagues in 2013 (180).